Abstract Details
|
Kyle Kern, MD, MS
(NIH)
PRESENTER |
No disclosure on file |
| Peony Pak, MD (UCLA David Geffen School of Medicine) | No disclosure on file |
| Rajarshi Mazumder, MD, MPH (UCLA) | Dr. Mazumder has nothing to disclose. |
| Dylan Alegria, MD, MS (Mercy Medical Group) | No disclosure on file |
| Phioanh L. Nghiemphu, MD, FAAN (UCLA Neuro-Oncology) | Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simpson Healthcare. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springswork. The institution of Dr. Nghiemphu has received research support from Erasca. The institution of Dr. Nghiemphu has received research support from Springswork. The institution of Dr. Nghiemphu has received research support from Children's Tumor Foundation. The institution of Dr. Nghiemphu has received research support from NIH-NCI . The institution of Dr. Nghiemphu has received research support from Genentech. The institution of Dr. Nghiemphu has received research support from DOD. The institution of Dr. Nghiemphu has received research support from Millenium. The institution of Dr. Nghiemphu has received research support from GCAR. |
| Lucas Restrepo, MD, PhD (UCLA Medical Center) | Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care. |